Latest Insider Transactions at Hologic Inc (HOLX)
This section provides a real-time view of insider transactions for Hologic Inc (HOLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HOLOGIC INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HOLOGIC INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2025
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-0.15%
|
$14,504
$74.15 P/Share
|
|
Nov 14
2025
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,874
-0.48%
|
$508,676
$74.15 P/Share
|
|
Nov 14
2025
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,333
-0.88%
|
$98,642
$74.15 P/Share
|
|
Nov 14
2025
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
561
-1.34%
|
$41,514
$74.15 P/Share
|
|
Nov 14
2025
|
Brandon Schnittker President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-1.0%
|
$13,172
$74.15 P/Share
|
|
Nov 14
2025
|
Anne M. Liddy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-1.18%
|
$24,938
$74.15 P/Share
|
|
Nov 14
2025
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-1.7%
|
$99,308
$74.15 P/Share
|
|
Nov 14
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-1.03%
|
$13,838
$74.15 P/Share
|
|
Nov 11
2025
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,679
-0.46%
|
$494,246
$74.6 P/Share
|
|
Nov 11
2025
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.13%
|
$13,172
$74.6 P/Share
|
|
Nov 11
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.99%
|
$13,394
$74.6 P/Share
|
|
Nov 11
2025
|
Brandon Schnittker President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-1.6%
|
$21,386
$74.6 P/Share
|
|
Nov 11
2025
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-1.65%
|
$51,948
$74.6 P/Share
|
|
Nov 11
2025
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,701
-2.11%
|
$125,874
$74.6 P/Share
|
|
Nov 11
2025
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-0.94%
|
$107,226
$74.6 P/Share
|
|
Nov 11
2025
|
Anne M. Liddy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
406
-1.4%
|
$30,044
$74.6 P/Share
|
|
Nov 10
2025
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
169,582
+10.55%
|
-
|
|
Nov 10
2025
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
16,823
+11.12%
|
-
|
|
Nov 10
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,047
+21.66%
|
-
|
|
Nov 10
2025
|
Brandon Schnittker President, GYN Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
12,113
+40.13%
|
-
|
|
Nov 10
2025
|
Jennifer M Schneiders President, Diag. Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
30,282
+41.56%
|
-
|
|
Nov 10
2025
|
Mark W. Horvath President, Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
13,458
+36.77%
|
-
|
|
Nov 10
2025
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,106
+36.87%
|
-
|
|
Nov 10
2025
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,741
+22.17%
|
-
|
|
Nov 10
2025
|
Anne M. Liddy General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,496
+37.65%
|
-
|
|
Nov 07
2025
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,405
-3.82%
|
$3,729,970
$74.1 P/Share
|
|
Nov 07
2025
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,420
-1.19%
|
$105,080
$74.1 P/Share
|
|
Nov 07
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-7.55%
|
$79,772
$74.1 P/Share
|
|
Nov 07
2025
|
Brandon Schnittker President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-2.26%
|
$10,212
$74.1 P/Share
|
|
Nov 07
2025
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-1.27%
|
$11,692
$74.1 P/Share
|
|
Nov 07
2025
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,927
-10.48%
|
$290,598
$74.1 P/Share
|
|
Nov 07
2025
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,427
-7.91%
|
$697,598
$74.1 P/Share
|
|
Nov 07
2025
|
Anne M. Liddy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
288
-2.45%
|
$21,312
$74.1 P/Share
|
|
Nov 04
2025
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,589
+5.96%
|
-
|
|
Nov 04
2025
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,095
+12.54%
|
-
|
|
Nov 04
2025
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
15,196
+11.32%
|
-
|
|
Nov 04
2025
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,116
+19.57%
|
-
|
|
Nov 04
2025
|
Mark W. Horvath President, Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
2,278
+19.05%
|
-
|
|
Nov 04
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,656
+15.68%
|
-
|
|
Oct 20
2025
|
Christiana Stamoulis Director |
SELL
Open market or private sale
|
Direct |
7,402
-13.52%
|
$540,346
$73.07 P/Share
|
|
Oct 20
2025
|
Christiana Stamoulis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,402
+11.91%
|
$266,472
$36.04 P/Share
|
|
Sep 22
2025
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
138,358
-3.46%
|
$9,131,628
$66.83 P/Share
|
|
Sep 22
2025
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
138,358
+9.15%
|
$5,395,962
$39.96 P/Share
|
|
May 30
2025
|
Brandon Schnittker President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-1.12%
|
$4,278
$62.17 P/Share
|
|
May 07
2025
|
Martin D Madaus Director |
BUY
Open market or private purchase
|
Indirect |
5,445
+50.0%
|
$299,475
$55.24 P/Share
|
|
Apr 07
2025
|
Wayde D. Mc Millan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,742
+50.0%
|
-
|
|
Feb 26
2025
|
Christiana Stamoulis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,864
+3.79%
|
-
|
|
Feb 26
2025
|
Stacey D. Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,864
+26.51%
|
-
|
|
Feb 26
2025
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,864
+7.62%
|
-
|
|
Feb 26
2025
|
Martin D Madaus Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,864
+45.8%
|
-
|